COMMUNIQUÉS West-GlobeNewswire

SuperSonic Imagine Showcasing Aixplorer Ultimate During the International Liver Congress (ILC) 2018

09/04/2018 - 19:00

SuperSonic Imagine will demonstrate the benefits of its Aixplorer Ultimate ultrasound system for the non-invasive assessment of chronic liver diseases AIX-EN-PROVENCE, France, April 09, 2018 (GLOBE NEWSWIRE) -- [...]

BioCorRx CEO Brady Granier and Legendary Soul Man Sam Moore Appear on Fox Business Network to Discuss the Company's Naltrexone Implant, Which Helps Combat Opioid Addiction

09/04/2018 - 18:25

ANAHEIM, CA, April 09, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company") , a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that Brady [...]

CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant le capital social

09/04/2018 - 18:12

Communiqué de Presse Information relative au nombre total de droits de vote et d'actions composant le capital social Dijon, le 09 avril 2018 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]

Ossur Hf : Transactions in relation to share buyback program

09/04/2018 - 18:01

Announcement no. 27/2018 Reykjavik, 09 April 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]

Innovation Pharmaceuticals Phase 2 Oral Mucositis Trial Additional Data Show Brilacidin-OM Demonstrated A Significant Reduction in the Incidence of Severe Oral Mucositis in Patients with Head and Neck Cancer (HNC) Receiving Aggressive Chemotherapy Regimen

09/04/2018 - 18:00

BEVERLY, Mass., April 09, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report further data analysis from its successfully [...]

Summit Therapeutics Provides Notice of Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2018

09/04/2018 - 16:01

OXFORD, United Kingdom and CAMBRIDGE, Mass., April 09, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ: SMMT ) will announce its financial results for the fourth quarter and fiscal year ended 31 [...]

Summit Therapeutics plc : Notice of Results

09/04/2018 - 16:01

Summit Therapeutics plc ("Summit", the "Company", or the "Group") Summit Therapeutics Provides Notice of Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2018 Oxford, UK, and Cambridge, MA, US, [...]

Scythian Biosciences Corp. Announces Progression of Global Expansion Efforts with Letter of Intent to Acquire MMJ Colombia Partners Inc.

09/04/2018 - 15:15

– Closing of the Acquisition will strengthen Scythian’s Latin American platform with three Colombian cannabis licences including for cultivation of CBD, THC and extraction of cannabis derivatives – – Colombian native Mr [...]

Wildflower Re “Brands”

09/04/2018 - 15:08

VANCOUVER, British Columbia, April 09, 2018 (GLOBE NEWSWIRE) -- Wildflower Marijuana Inc. (CSE:SUN) (the “Company”) held its Annual and Special Meeting on April 6 where shareholders overwhelming approved to change the [...]

Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension

09/04/2018 - 15:01

Pivotal Trial Now Underway to Study Effect of Investigational Procedure in Patients with High Blood Pressure DUBLIN - April 9, 2018 - Medtronic plc (NYSE: MDT ) today announced U.S. Food and Drug Administration (FDA) [...]

OrthoPediatrics Corp. Announces Sponsorship of 2018 EPOS Meeting and Lunch Symposium

09/04/2018 - 15:00

WARSAW, Ind., April 09, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS ), a company exclusively focused on advancing the field of pediatric orthopedics, today announced it will continue its Diamond [...]

Canada House Announces Appointment of Chief Financial Officer

09/04/2018 - 14:47

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, April 09, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) today [...]

Data Monitoring Committee (DMC) Completes Planned Safety and Data Review of Celsion’s Phase III OPTIMA Study of ThermoDox® in Primary Liver Cancer

09/04/2018 - 14:30

DMC Unanimously Recommends Continuation of OPTIMA Study Based on Safety Data From 411 Patients; Enrollment Now at 80% Blinded Progression-Free Survival (PFS) Rate in the OPTIMA Study is Consistent With the Subgroup [...]

Precision Therapeutics, Inc. Engages Richard Gabriel to Drive Business Development Strategy for its TumorGenesis Subsidiary

09/04/2018 - 14:30

Richard Gabriel, BS, MBA is a board member of Precision Therapeutics and spearheaded the licensing of new technologies for 3D cell culturing from 48 Hour Discovery, SyntArray and CellBridge MINNEAPOLIS, April 09, 2018 ( [...]

Physeon Selects RCRI for Pivotal Study of Veinplicity Device

09/04/2018 - 14:30

Recent Clinical Trial Indicated Device had a Dilatory Effect 38% Greater than Standard of Care SCHAFFHAUSEN, Switzerland, April 09, 2018 (GLOBE NEWSWIRE) -- Physeon GmbH (“Physeon” or the “Company”), a leading developer [...]

Minerva Neurosciences Screens First Patient in Phase 2b Trial of MIN-117 to Treat Major Depressive Disorder

09/04/2018 - 14:30

Multi-center trial to enroll approximately 324 patients at approximately 40 clinical sites in U.S. and Europe WALTHAM, Mass., April 09, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV ), a clinical- [...]

EyeGate Receives FDA Feedback on Investigational Device Exemption Amendment for Second Pilot Study of Ocular Bandage Gel

09/04/2018 - 14:30

Feedback Provides Clear Path to Resubmission; Expected July 2018 WALTHAM, Mass., April 09, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG ) (“EyeGate” or the “Company”), a clinical-stage, specialty [...]

OncoMed to Present Multiple Preclinical Abstracts Related to Immuno-Oncology Programs at the 2018 American Association for Cancer Research Annual Meeting

09/04/2018 - 14:30

REDWOOD CITY, Calif., April 09, 2018 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (NASDAQ: OMED ), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, [...]

Genocea to Present Data at Upcoming AACR Annual Meeting Further Highlighting ATLAS Platform Ability to Identify and Characterize Neoantigens for Cancer Vaccines

09/04/2018 - 14:05

CAMBRIDGE, Mass., April 09, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc . (NASDAQ: GNCA ), a biopharmaceutical company developing neoantigen cancer vaccines, today announced upcoming presentations at the 2018 [...]